Xencor (XNCR) Invested Capital (2013 - 2026)
Xencor (XNCR) reported Invested Capital of $542.0 million for Q1 2026, down 21.72% year-over-year from $692.4 million in Q1 2025, and down 20.15% quarter-over-quarter from $678.9 million in Q4 2025.
Xencor (XNCR) Invested Capital (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Invested Capital data on file, last reported at $542.0 million in Q1 2026.
- Invested Capital for Q1 2026 came in at $542.0 million, down 21.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $542.0 million (down 21.72% YoY), and the FY2025 annual result was $678.9 million, down 6.04% from the prior year.
- Invested Capital eased to $542.0 million in Q1 2026 per XNCR's latest filing, from $678.9 million in the prior quarter.
- Over five years, Invested Capital peaked at $763.0 million in Q1 2022 and troughed at $542.0 million in Q1 2026.
- A 5-year average of $683.9 million and a median of $683.6 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2026: Invested Capital surged 30.74% in 2022, then slipped 21.72% in 2026.
- A 5-year view of Invested Capital shows it stood at $727.5 million in 2022, then retreated by 5.18% to $689.8 million in 2023, then increased by 4.74% to $722.5 million in 2024, then retreated by 6.04% to $678.9 million in 2025, then dropped by 20.15% to $542.0 million in 2026.
- Business Quant data shows XNCR's Invested Capital at $542.0 million in Q1 2026, $678.9 million in Q4 2025, and $670.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 542.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 542.04 Mn |
| Dec 31, 2025 | 678.85 Mn |
| Sep 30, 2025 | 670.68 Mn |
| Jun 30, 2025 | 670.64 Mn |
| Mar 31, 2025 | 692.42 Mn |
| Dec 31, 2024 | 722.47 Mn |
| Sep 30, 2024 | 750.38 Mn |
| Jun 30, 2024 | 587.64 Mn |
| Mar 31, 2024 | 633.94 Mn |
| Dec 31, 2023 | 689.80 Mn |
| Sep 30, 2023 | 669.01 Mn |
| Jun 30, 2023 | 678.88 Mn |
| Mar 31, 2023 | 683.58 Mn |
| Dec 31, 2022 | 727.50 Mn |
| Sep 30, 2022 | 722.70 Mn |
| Jun 30, 2022 | 742.34 Mn |
| Mar 31, 2022 | 763.02 Mn |
| Dec 31, 2021 | 733.50 Mn |
| Sep 30, 2021 | 618.86 Mn |
| Jun 30, 2021 | 646.94 Mn |